Cite

HARVARD Citation

    Smith, K. et al. (n.d.). 139P The timing, dynamics, and co-occurrence of immune-related adverse events with a PD-L1 inhibitor in non-small cell lung cancer. Immuno-oncology technology. p. . [Online]. 
  
Back to record